Clinical Trials Directory

Trials / Completed

CompletedNCT00689832

Protopic Ointment in Children Atopic Eczema

Comparative, Multicentre, Randomised, Double-blind Study to Assess the Efficacy of Tacrolimus 0.03% Ointment Versus Fluticasone 0.005% Ointment in Children Aged 2 Years or Over Suffering From Moderate to Severe Atopic Dermatitis.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
487 (actual)
Sponsor
Astellas Pharma Inc · Industry
Sex
All
Age
2 Years – 15 Years
Healthy volunteers
Not accepted

Summary

Children with atopic eczema and a poor response to topical corticosteroid applied either Protopic or Fluticasone ointment twice a day for 3 weeks. They could continue during 3 more weeks once a day if needed.

Detailed description

Treatments were to be applied twice daily until clearance, for a maximum of 3 weeks and then, in case of uncleared residual lesions, once daily for up to 3 further weeks. In the event of a flare-up the treatment was to be resumed twice a day until the end of the study. Statistical methods: An interim analysis was performed on 30% of the planned total sample size, i.e. 140 included patients who had completed the study, to reassess the assumptions made during the planning phase.

Conditions

Interventions

TypeNameDescription
DRUGTacrolimus 0.03%ointment
DRUGFluticasone 0.005%ointment

Timeline

Start date
2004-02-01
Primary completion
2005-08-01
Completion
2005-08-01
First posted
2008-06-04
Last updated
2014-09-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00689832. Inclusion in this directory is not an endorsement.